Centralization tendency in zoning plans
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
The aim of this study is to determine whether it is treated correctly as to choose institution authorized to make the zoning plans and whether the choice in question indicates a trend; also, to make suggestions regarding the solution of the drawbacks and problems caused by this trend. In order to achieve this goal, zoning plan types were deeply examined through scrutinizing the concepts of local administration theory, authority sharing and city development planning. In particular, concepts such as local autonomy, administrative tutelage, principle of local administration, local common need, subsidiarity principle have been given detailed coverage, taking into account legal regulations, doctrine and judicial decisions; in the light of these concepts, the tendency on centralization and its drawbacks in zoning plans were brought up for discussion, and suggestions were made for the solution of authority problems in planning. Keywords: Local authorities, central administration, authority sharing, zoning plan, centralization.
Author
Muhammet Gelir
How to Cite
Muhammet Gelir (Master Thesis). Centralization tendency in zoning plans, 2021, Yeditepe University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)